-- Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update
-- B y   D a v i d   W a i n e r
-- 2012-05-24T11:39:08Z
-- http://www.bloomberg.com/news/2012-05-24/teva-jumps-as-new-ceo-jeremy-levin-set-to-give-guidance-update.html
Teva Pharmaceutical Industries Ltd. (TEVA) 
rose the most in almost two months before new Chief Executive
Officer Jeremy Levin gives an update on financial guidance.  The stock  of the worldâ€™s largest generic drugmaker jumped
the most since April 1, adding 2.4 percent to 153 shekels at
2:36 p.m. in Tel Aviv.  To contact the reporter on this story:
David Wainer in Tel Aviv at 
 dwainer3@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  